What is it about?
This is a rare case of severe autoimmune hemolytic anemia triggered by pegylated interferon during combination therapy for chronic HCV.
Featured Image
Why is it important?
This case incidated that close monitoring of haematological values was necessary before and during the treatment of chronic HCV with inferon and ribavirin.
Perspectives
Our case incidated that severe autoimmune hemolytic anemia can be triggered by pegylated interferon during combination therapy for chronic HCV, and that direct antiviral drugs may be an optimal choice for chronic hepatitis C patients who experience virologic failure after IFN-based treatment.
Shasha Wang
Read the Original
This page is a summary of: Severe autoimmune hemolytic anemia during pegylated interferon plus ribavirin treatment for chronic hepatitis C: a case report, Clinical Case Reports, July 2017, Wiley,
DOI: 10.1002/ccr3.1098.
You can read the full text:
Contributors
The following have contributed to this page
